Response to late diagnosis of COVID-19 and hypercoagulable state.
作者信息
Desdiani Desdiani
机构信息
Faculty of Medicine, Universitas Sultan Ageng Tirtayasa, Cilegon, Indonesia.
出版信息
Can J Respir Ther. 2022 Jul 26;58:121. doi: 10.29390/cjrt-2022-033. eCollection 2022.
Abstract
摘要
相似文献
1
Response to late diagnosis of COVID-19 and hypercoagulable state.对新冠病毒病延迟诊断及高凝状态的应对措施
Can J Respir Ther. 2022 Jul 26;58:121. doi: 10.29390/cjrt-2022-033. eCollection 2022.
2
Late diagnosis of COVID-19 in a 34-year-old man in a hypercoagulable state: A case report.一名处于高凝状态的34岁男性新冠肺炎的延迟诊断：病例报告
Can J Respir Ther. 2022 Apr 20;58:49-52. doi: 10.29390/cjrt-2021-028. eCollection 2022.
3
Thromboelastography findings in critically ill COVID-19 patients.危重症COVID-19患者的血栓弹力图检查结果
J Thromb Thrombolysis. 2021 May;51(4):961-965. doi: 10.1007/s11239-020-02300-7. Epub 2020 Oct 4.
4
Re: Late diagnosis of COVID-19 and hypercoagulable state.关于：新冠病毒病的延迟诊断与高凝状态
Can J Respir Ther. 2022 Jun 22;58:84. doi: 10.29390/cjrt-2022-026. eCollection 2022.
5
Persistent Hypercoagulable State in COVID-19: A Case Series of COVID-19 Associated Pulmonary Embolism.COVID-19中的持续性高凝状态：COVID-19相关肺栓塞病例系列
J Glob Infect Dis. 2021 Jan 29;13(1):38-41. doi: 10.4103/jgid.jgid_180_20. eCollection 2021 Jan-Mar.
6
Urinary proteome analysis of acute hypercoagulable state in rat model induced by ε-aminocaproic acid.尿蛋白质组分析在 ε-氨基己酸诱导的大鼠急性高凝状态模型中的应用。
Biomed Pharmacother. 2019 Feb;110:275-284. doi: 10.1016/j.biopha.2018.11.148. Epub 2018 Dec 2.
7
Marantic Endocarditis Associated with COVID-19: A Rare Case Report of a Potentially Deadly Disease.与新型冠状病毒肺炎相关的消耗性心内膜炎：一例潜在致命疾病的罕见病例报告
Eur J Case Rep Intern Med. 2021 Mar 19;8(3):002409. doi: 10.12890/2021_002409. eCollection 2021.
8
Proteome Analysis of Urinary Biomarkers in Acute Hypercoagulable State Rat Model.急性高凝状态大鼠模型尿液生物标志物的蛋白质组学分析
Front Mol Biosci. 2021 Apr 30;8:634606. doi: 10.3389/fmolb.2021.634606. eCollection 2021.
9
Acquired and Hereditary Hypercoagulable States in Patients with Continuous Flow Left Ventricular Assist Devices: Prevalence and Thrombotic Complications.接受持续血流左心室辅助装置治疗患者的获得性和遗传性高凝状态：患病率及血栓形成并发症
J Card Fail. 2016 Jul;22(7):501-11. doi: 10.1016/j.cardfail.2015.12.020. Epub 2016 Jan 4.
10
A Case Series of HIV-Seropositive Patients and Hypercoagulable State-Is It Difficult to Treat Even with Therapeutic Anticoagulation?一组HIV血清阳性患者与高凝状态病例系列——即使采用治疗性抗凝治疗也难以治疗吗？
Int J Angiol. 2013 Jun;22(2):105-8. doi: 10.1055/s-0033-1334868.
引用本文的文献
1
Anti-infection effects of heparin on SARS-CoV-2 in a diabetic mouse model.肝素对糖尿病小鼠模型中 SARS-CoV-2 的抗感染作用。
Zool Res. 2023 Nov 18;44(6):1003-1014. doi: 10.24272/j.issn.2095-8137.2023.108.
本文引用的文献
1
Re: Late diagnosis of COVID-19 and hypercoagulable state.关于：新冠病毒病的延迟诊断与高凝状态
Can J Respir Ther. 2022 Jun 22;58:84. doi: 10.29390/cjrt-2022-026. eCollection 2022.
2
Late diagnosis of COVID-19 in a 34-year-old man in a hypercoagulable state: A case report.一名处于高凝状态的34岁男性新冠肺炎的延迟诊断：病例报告
Can J Respir Ther. 2022 Apr 20;58:49-52. doi: 10.29390/cjrt-2021-028. eCollection 2022.
3
Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia.新型冠状病毒肺炎肺血管内凝血病变的免疫机制
Lancet Rheumatol. 2020 Jul;2(7):e437-e445. doi: 10.1016/S2665-9913(20)30121-1. Epub 2020 May 7.
4
Coagulation abnormalities and thrombosis in patients with COVID-19.新型冠状病毒肺炎患者的凝血异常与血栓形成
Lancet Haematol. 2020 Jun;7(6):e438-e440. doi: 10.1016/S2352-3026(20)30145-9. Epub 2020 May 11.
5
Incidence of thrombotic complications in critically ill ICU patients with COVID-19.COVID-19 重症监护病房危重症患者的血栓并发症发生率。
Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.
Zotero 插件